Fujian Province Cancer Hospital ( Site 1178)

Fuzhou, Fujian 350014

0 studies enrolling now · 1 studies all time

What they study most

Colorectal Cancer

Studies at this site

• A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007) — Completed